Navigation Links
Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
Date:1/14/2010

EMERYVILLE, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) announced today the publication of their results from its phase 1B clinical trial of Bezielle (BZL101) for metastatic breast cancer. The results of the study are available online in Breast Cancer Research and Treatment and demonstrate that Bezielle continues to be safe and well tolerated with clinical evidence of anticancer activity in a heavily pretreated population of women diagnosed with metastatic breast cancer. Preliminary results from this study were released previously by the Company.

The purpose of the phase 1B clinical trial was to identify the maximum tolerated dose of Bezielle and to determine the safety and feasibility of the company's novel, oral, anticancer treatment. A total of 27 women with late stage breast cancer were enrolled to the phase 1B trial. The 27 enrolled women had failed an average of six prior therapies since diagnosis with metastatic breast disease and expected survival pre-trial was 90–120 days. To date, a total of 48 women with advanced breast cancer have been treated with Bezielle in two early phase clinical trials.

Highlights of the Bezielle phase 1B clinical trial are as follows:

  • Independent radiology showed 6 patients had stable disease.
  • Independent radiology showed 3 patients had evidence of tumor regression consistent with a minimal tumor response (>0% and <30%).
  • Three patients had stable disease for >120 days.
  • Four patients discontinued Bezielle with stable disease; one was on Bezielle for 449 days and had evidence of minimal tumor regression and continues to be stable for 700+ days. A second patient remained stable for 836 days a
    '/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... --  Mallinckrodt plc (NYSE: MNK ), a leading ... at the Bank of America Merrill Lynch 2015 Health Care ... Las Vegas, Nev. Matthew ... Cole Lannum , Senior Vice President of Investor Strategy ... session scheduled to begin at 3 p.m. Eastern / noon ...
(Date:5/4/2015)... 2015  Array BioPharma Inc. (NASDAQ: ARRY ... of its fiscal year ending June 30, 2015. ... noted, "With the close of the Novartis-GSK transaction, ... innovative oncology products in Phase 3, with plans ... These transformative transactions have accelerated our path to ...
(Date:5/4/2015)... , May 4, 2015  Prometheus Research ... the American Optometric Association (AOA) to build a ... outcomes for the millions of patients treated by ... Outcomes Registry for Eyecare (MORE) will leverage ... facilitate efficient secondary uses of essential health and ...
Breaking Medicine Technology:Mallinckrodt To Present At Bank Of America Merrill Lynch 2015 Health Care Conference 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 10American Optometric Association, Prometheus Research to Create Transformative Health Outcomes Registry 2
... Sept. 14 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Business Development of BioMarin, will present a company update at ... on Tuesday, September 21, 2010 at 3:30 p.m. ET.   ... of the conference call via the investor section of the ...
... WORCESTER, Mass., Sept. 14 Generex Biotechnology Corporation (Nasdaq: ... in drug delivery for metabolic diseases through the inner ... entered into an exclusive Product Licensing & Distribution Agreement ... marketing, distribution and sale of Generex Oral-lyn™, the Company,s ...
Cached Medicine Technology:BioMarin to Present at the UBS Global Life Sciences Conference 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 3
(Date:5/4/2015)... Elisabeth Rosenthal’s article* on “balance billing” ... the healthcare fraternity as well as patients about ... of balance billing. In definition, balance billing is ... patient for the difference between what the patient's ... provider chooses to charge. Rosenthal’s article talks about ...
(Date:5/4/2015)... May 04, 2015 For partners who’d ... new lubricant -- Astroglide TTC™ (Trying to Conceive) ... and alter pH levels, Astroglide TTC™ is specially formulated ... According to the Centers for Disease Control, an average ... getting pregnant or sustaining a pregnancy, and over ...
(Date:5/4/2015)... Peacock Alley knows we all ... “My mother was the most beautiful woman I ever saw.” ... feminine prints and textures to remind her just ... the Eloise Robe to get you there. The beautiful Monet-inspired ... and tapered waist. It is available in small/medium or large/extra ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Barbara Crone has joined ... enhance the well being of the men, women and families who ... followed by providing care for families in the home. ... Nurse Practitioner began wondering if I could complete their care with ... own children with my mentor Nurse Midwife, I knew it was ...
(Date:5/3/2015)... Indiana (PRWEB) May 03, 2015 Indiana ... Service Provider announces Bank Computer Services, Inc (BCS) has ... Prout, BCS’ President states, “The technology, service, and working ... really like is the local feel you get with ... and managed company; IFN makes local decisions and operates ...
Breaking Medicine News(10 mins):Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3
... women should consider the real cost of the procedure beyond the ... surgeon, advises of the importance of choosing a cosmetic surgeon wisely based ... ... Paramus, NJ (PRWeb) January 27, 2009 - You may be under the ...
... Solutions ( http://www.ahsrcm.com ), a leading provider of ... it has entered into an agreement with Staten ... of physician billing and A/R management services for ... the agreement, AHS will acquire the existing SIUH ...
... Attorneys representing individual physicians and the physician partnership ... praised today,s announcement that Texas Attorney General Greg ... similar violations of the state antitrust laws.The Attorney ... an agreed injunction prohibiting Memorial Hermann from engaging ...
... Withholding Eucharist From Pro-Abortion Catholic PelosiWASHINGTON, Jan. 26 ... Kenney issued the following statement today regarding Speaker of ... Sunday. Rep. Pelosi stated that the millions of dollars ... "reduce costs to the states and to the federal ...
... American Heart Association science advisory concludes that omega-6 fatty acids ... are a beneficial part of a heart-healthy eating plan. ... issue of Circulation: Journal of the American Heart Association. ... Fatty Acids Click here for the full ...
... be hidden in DNA , , MONDAY, Jan. 26 (HealthDay News) ... make you human are genes that may determine whether you ... two types of twins shows that genetics might affect social ... are closing in on some of those "personality" genes. , ...
Cached Medicine News:Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the &#8220;Real Cost&#8221; 2Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the &#8220;Real Cost&#8221; 3Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the &#8220;Real Cost&#8221; 4Health News:Staten Island University Hospital Chooses Advantedge Healthcare Solutions for Employed Physician Billing 2Health News:Staten Island University Hospital Chooses Advantedge Healthcare Solutions for Employed Physician Billing 3Health News:Staten Island University Hospital Chooses Advantedge Healthcare Solutions for Employed Physician Billing 4Health News:Lawyers React to Texas Attorney General's Lawsuit, Settlement Against Houston's Memorial Hermann 2Health News:American Life League Statement on Pelosi's State-Enforced War on Preborn Babies 2Health News:Popular or Not? Your Genes May Help Decide 2Health News:Popular or Not? Your Genes May Help Decide 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: